Research graph
References from Programmable antigen-presenting scaffolds expand rare tumor-antigen-specific T cells from peripheral blood. Local targets link to admitted publications; unresolved targets remain external evidence.
SPEARHEAD-1: a single-arm phase 2 trial of afamitresgene autoleucel (afami-cel) in advanced synovial sarcoma and myxoid/round cell liposarcoma
10.1016/s0140-6736(24)00319-2 · 2024 · External reference
10.1056/nejmoa2210233
10.1056/nejmoa2210233 · External reference
10.1136/jitc-2022-005755
10.1136/jitc-2022-005755 · External reference
10.1038/s41591-018-0266-5
10.1038/s41591-018-0266-5 · External reference
Unresolved reference
External reference
10.1038/s41586-021-03704-y
10.1038/s41586-021-03704-y · External reference
10.1038/s41568-019-0235-4
10.1038/s41568-019-0235-4 · External reference
10.1016/j.ccell.2022.03.012
10.1016/j.ccell.2022.03.012 · External reference
10.1016/j.ccell.2023.11.005
10.1016/j.ccell.2023.11.005 · External reference
10.1038/s41467-019-08304-z
10.1038/s41467-019-08304-z · External reference
10.1038/nm.4051
10.1038/nm.4051 · External reference
Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
10.1016/j.celrep.2019.07.106 · 2019 · External reference
10.1038/s41598-018-23943-w
10.1038/s41598-018-23943-w · External reference
Impaired monocyte-derived dendritic cell phenotype in prostate cancer patients: A phenotypic comparison with healthy donors
2024 · External reference
10.1136/jitc-2023-006847
10.1136/jitc-2023-006847 · External reference
Dendritic cell-mimicking scaffolds for ex vivo T cell expansion
2022 · External reference
10.1172/jci177082
10.1172/jci177082 · External reference
10.1158/2326-6066.cir-18-0881
10.1158/2326-6066.cir-18-0881 · External reference
Rapid Expansion of Highly Functional Antigen-Specific T cells from Melanoma Patients by Nanoscale Artificial Antigen Presenting Cells
10.1158/1078-0432.ccr-19-3487 · 2020 · External reference
Dendritic cell-mimicking scaffolds for ex vivo T cell expansion
2023 · External reference
Unresolved reference
External reference
10.1038/s41596-019-0249-0
10.1038/s41596-019-0249-0 · External reference
10.1038/nbt.4047
10.1038/nbt.4047 · External reference
10.1038/s41467-023-36126-7
10.1038/s41467-023-36126-7 · External reference
10.1084/jem.190.5.705
10.1084/jem.190.5.705 · External reference
10.1084/jem.180.1.347
10.1084/jem.180.1.347 · External reference
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
10.4049/jimmunol.160.4.1750 · 1998 · External reference
10.4049/jimmunol.175.4.2261
10.4049/jimmunol.175.4.2261 · External reference
10.1182/blood-2012-05-431718
10.1182/blood-2012-05-431718 · External reference
10.1038/nm.2446
10.1038/nm.2446 · External reference
10.1038/nature22991
10.1038/nature22991 · External reference
10.1038/s41591-020-01206-4
10.1038/s41591-020-01206-4 · External reference
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy
10.1038/s41467-026-68680-1 · 2026 · External reference
10.1038/nrc3322
10.1038/nrc3322 · External reference
10.1126/science.abb9847
10.1126/science.abb9847 · External reference
10.1038/s41587-023-01767-y
10.1038/s41587-023-01767-y · External reference
10.1186/s12859-017-1544-9
10.1186/s12859-017-1544-9 · External reference
